Carnick & Kubik’s Idexx Laboratories IDXX Stock Holding History

Carnick & Kubik’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$736K	Hold	9,400	–	–	0.22%	124
2015 Q4	$685K	Hold	9,400	–	–	0.44%	75
2015 Q3	$698K	Hold	9,400	–	–	0.49%	69
2015 Q2	$603K	Hold	9,400	–	–	0.49%	77
2015 Q1	$726K	Sell	9,400 -1,100	-10%	-$85.6K	0.61%	60
2014 Q4	$778K	Sell	10,500 -1,600	-13%	-$112K	0.66%	53
2014 Q3	$713K	Hold	12,100	–	–	0.66%	58
2014 Q2	$808K	Hold	12,100	–	–	0.81%	42
2014 Q1	$734K	Hold	12,100	–	–	0.7%	51
2013 Q4	$644K	Hold	12,100	–	–	0.58%	60
2013 Q3	$603K	Hold	12,100	–	–	0.92%	44
2013 Q2	$543K	Buy	+12,100	New	+$529K	0.67%	57

Other funds holding IDXX

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Carnick & Kubik's IDXX Position: Q1 2016 in Review

Carnick & Kubik held its Idexx Laboratories (IDXX) position steady in Q1 2016 at 9,400 shares worth $736K. The position accounts for 0.22% of the portfolio, ranked #124.

Carnick & Kubik first reported a position in IDXX in Q2 2013 and has held it in 12 quarters since. The position peaked at $808K in Q2 2014. 376 funds tracked by Wall St. Rank hold IDXX as of Q1 2016.

Carnick & Kubik held 9,400 shares of Idexx Laboratories worth $736K as of Q1 2016.
Carnick & Kubik left its Idexx Laboratories share count unchanged in Q1 2016.
Idexx Laboratories made up 0.22% of Carnick & Kubik's portfolio in Q1 2016, its #124 holding.
Carnick & Kubik first reported a position in Idexx Laboratories in Q2 2013 and has held it in 12 quarters since.
Carnick & Kubik's Idexx Laboratories position peaked at $808K in Q2 2014.
376 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.